Y.-S. Hon, C.-F. Lee / Tetrahedron 57 (2001) 6181±6188
6185
1
mp 59±608C; H NMR (CDCl3, 400 MHz) d 0.94 (d, J
were ®ltered through Celite and concentrated in vacuo to
give the desired product 10b in 87% yield. Needless to
purify, this product can be used for the further reaction.
1H NMR (CDCl3, 400 MHz) d 1.61±1.73 (m, 12H), 3.55±
3.58 (m, 6H), 4.98 (t, J4.8 Hz, 6H); 13C NMR (CDCl3,
100 MHz) d 27.6, 32.0, 62.6, 102.4; IR (KBr) 3372, 1447,
1360 cm21; MS m/z (relative intensity): 265 (M111, 2),
229 (22), 159 (43), 71 (100); HRMS Calcd for C12H25O6
(M11H): 265.1652, found: 265.1651.
6.8 Hz, 18H, ±CH3), 1.83±1.88 (m, 3H), 4.50 (d, J5.5 Hz,
3H, ±OCHO); 13C NMR (CDCl3, 100 MHz) d16.7, 32.4,
104.7; IR (KBr) 2958, 1470, 1355, 1263 cm21; MS m/z
(relative intensity): 216 (M1, 1), 199 (94), 127 (100), 98
(55), 81 (83); Anal. Calcd for C12H24O3: C, 66.63; H, 11.18,
found: C, 66.59; H, 11.14.
4.1.5. 2,4,6-Tricyclohexyl-1,3,5-trioxane (5a). White
solid, mp 196±1988C; 1H NMR (CDCl3, 400 MHz) d
1.01±1.24 (m, 15H), 1.58±1.83 (m, 18H), 4.49 (d,
J5.6 Hz, 3H, ±OCHO±); 13C NMR (CDCl3, 100 MHz)
d 25.6, 26.5, 27.0, 41.9, 104.3; IR (KBr) 2921, 1466,
1351, 1231 cm21; MS m/z (relative intensity): 336 (M1,
2), 225 (79), 113 (92), 95 (100); Anal. Calcd for
C21H36O3: C, 74.95; H, 10.78, found: C, 74.87; H, 10.78.
4.1.11. 2,4,6-Tri(4-benzoxybutyl)-1,3,5-trioxane (11a).
1H NMR (CDCl3, 400 MHz) d 1.55±1.60 (m, 6H), 1.72±
1.82 (m, 12H), 4.30±4.33 (m, 6H), 4.89 (t, J5.2 Hz, 3H,
±OCHO), 7.26±7.56 (m, 9H, Ar±H), 8.02±8.04 (m, 6H,
Ar±H); 13C NMR (CDCl3, 100 MHz) d 20.1, 28.5, 33.9,
64.7, 101.2, 128.3, 129.5, 130.4, 132.8, 166.6; IR (KBr)
3059, 2949, 1724, 1599, 1452, 1365 cm21; MS m/z (relative
intensity): 617 (M1, 5), 414 (17), 273 (10), 207 (100), 154
(16); HRMS Calcd for C36H41O9 (M12H): 617.2745,
found: 617.2751; Anal. Calcd for C36H42O9: C, 68.74; H,
6.29. Found: C, 68.77; H, 6.32
4.1.6. 2,4,6-Tri(2,6-dimethylheptyl)-1,3,5-trioxane (7a).
1H NMR (CDCl3, 400 MHz) d 0.86 (d, J6.6 Hz, 18H,
±CH3), 0.91 (d, J6.5 Hz, 9H, ±CH3), 1.12±1.31 (m,
18H), 1.47±1.53 (m, 6H), 1.68±1.69 (m, 6H), 4.94 (t, J
5.0 Hz, 3H, ±OCHO); 13C NMR (CDCl3, 100 MHz) d 19.8,
22.6, 22.7, 24.5, 28.2, 37.3, 39.2, 41.4, 100.8; IR (KBr)
2921, 1466, 1369 cm21; MS m/z (relative intensity): 468
(M1, 2), 313 (46), 155 (84), 83 (69), 69 (100); HRMS
Calcd for C30H60O3: 468.4545, found: 468.4533.
4.1.12.
2,4,6-Tri(3-methoxycarbonylpropyl)-1,3,5-tri-
1
oxane (12a). H NMR (CDCl3, 400 MHz) d 1.69±1.77
(m, 12H), 2.35 (t, J7.2 Hz, 6H), 3.67 (s, 9H, ±CH3),
4.87 (t, J4.8 Hz, 3H, ±OCHO); 13C NMR (CDCl3,
100 MHz) d 19.0, 33.5, 33.6, 51.5, 100.9, 173.8; IR (KBr)
2940, 1738, 1443, 1360 cm21; MS m/z (relative intensity):
391 (M111, 3), 261 (15), 131 (100), 99 (84).
1
4.1.7. 2,4,6-Tri(9-decenyl)-1,3,5-trioxane (8a). H NMR
(CDCl3, 400 MHz) d 1.28±1.39 (m, 36H), 1.63±1.69 (m,
6H), 2.01±2.06 (m, 6H), 4.83 (t, J5.3 Hz, 3H, ±OCHO),
4.91±5.01 (m, 6H, ±CHCH2), 5.77±5.86 (m, 3H,
±CHCH2); 13C NMR (CDCl3, 100 MHz) d 23.5, 28.9,
29.1, 29.3, 29.4, 29.5, 33.8, 34.4, 101.7, 114.1, 139.2; IR
(KBr) 3068, 2921, 1641, 1466, 1355 cm21; MS m/z (relative
intensity): 504 (M1, 1), 335 (12), 149 (43), 95 (100); Anal.
Calcd for C33H60O3: C, 78.51; H, 11.98. Found: C, 78.56; H,
12.06.
4.1.13. 2,4,6-Tri(4-methoxycarbonylbutyl)-1,3,5-trioxane
(13a). H NMR (CDCl3, 400 MHz) d 1.40±1.46 (m, 6H),
1
1.61±1.69 (m, 12H), 2.31 (t, J7.6 Hz, 6H), 3.66 (s, 9H,
±CH3), 4.83 (t, J5.2 Hz, 3H, ±OCHO); 13C NMR (CDCl3,
100 MHz) d 23.0, 24.6, 33.8, 33.9, 51.4, 101.2, 174.0; IR
(KBr) 2940, 1738, 1438, 1365 cm21; MS m/z (relative inten-
sity): 432 (M1, 1), 289 (14), 145 (100), 113 (56); HRMS
Calcd for C21H37O9 (M11H): 433.2438, found: 433.2443.
1
4.1.8. 2,4,6-Tri(4-pentenyl)-1,3,5-trioxane (9a). H NMR
(CDCl3, 400 MHz) d 1.49±1.53 (m, 6H), 1.66±1.71 (m,
6H), 2.05±2.10 (m, 6H), 4.85 (t, J5.3 Hz, 3H, ±OCHO),
4.94±5.03 (m, 6H, ±CHCH2), 5.76±5.80 (m, 3H, ±
CHCH2); 13C NMR (CDCl3, 100 MHz) d 22.8, 33.4, 33.8,
101.4, 114.7, 138.4; IR (KBr) 3068, 2930, 1641, 1443,
1355 cm21; MS m/z (relative intensity): 294 (M1, 10), 252
(22), 197 (100), 154 (50), 137 (57); HRMS Calcd for
C18H30O3: 294.2196, found: 294.2192.
4.1.14. 2,4,6-Tri(4-carboxybutyl)-1,3,5-trioxane (13b). A
solution of compound 13a (261 mg, 0.603 mmol) in 6 mL of
MeOH was added to a solution of KOH (118 mg,
2.11 mmol) in 3 mL of water. The reaction mixtures were
heated up to re¯ux for 30 min. Subsequently, the reaction
mixture was cooled down to room temperature, neutralized
by 1N HCl until the pH was between 4±5 and then extracted
with CH2Cl2 three times. The organic layer was dried over
MgSO4 and concentrated to give compound 13b (123 mg) in
52% yield. 1H NMR (D2O, 400 MHz) d 1.46±1.48 (m, 6H),
1.62±1.73 (m, 12H), 2.29 (t, J7.4 Hz, 6H), 5.18 (t, J
5.1 Hz, 3H); 13C NMR (D2O, 100 MHz) d 22.8, 25.2,
33.3, 36.5, 1.2.2, 182.3; IR (KBr) 2949, 1710, 1415, 1369,
1300 cm21
4.1.9. 2,4,6-Tri(3-benzyloxypropyl)-1,3,5-trioxane (10a).
1H NMR (CDCl3, 400 MHz) d 1.72±1.77 (m, 12H), 3.48 (t,
J5.6 Hz, 6H, ±OCH2±), 4.49 (s, 6H, ±OCH2Ph), 4.83 (t,
J4.8 Hz, 3H, ±OCHO), 7.26±7.33 (m, 15H, Ar±H); 13C
NMR (CDCl3, 100 MHz) d 23.8, 31.1, 69.9, 72.8, 101.1,
127.4, 127.5, 128.3, 138.5; IR (KBr) 3032, 2857, 1682,
1447, 1360 cm21; MS m/z (relative intensity): 534 (M1,
39), 358 (10), 249 (10), 179 (100); HRMS Calcd for
C32H41O6 (M12H): 533.2903, found: 533.2909.
4.1.15.
2,4,6-Tri(5-methoxycarbonylpentyl)-1,3,5-tri-
1
oxane (14a). H NMR (CDCl3, 400 MHz) d 1.27±1.39
(m, 12H), 1.55±1.64 (m, 12H), 2.26 (t, J7.6 Hz, 6H),
3.61 (s, 9H, ±CH3), 4.78 (t, J5.3 Hz, 3H, ±OCHO); 13C
NMR (CDCl3, 100 MHz) d 23.0, 24.7, 28.7, 33.8, 34.1,
51.3, 101.3, 174.0; IR (KBr) 2930, 2857, 1738, 1438,
1360 cm21; MS m/z (relative intensity): 475 (M111, 1),
285 (20), 159 (100), 81 (43); HRMS Calcd for C24H41O9
(M1-H): 473.2751, found: 473.2758
4.1.10. 2,4,6-Tri(3-hydroxypropyl)-1,3,5-trioxane (10b).
Compound 10a (471 mg, 0.88 mmol) in 20 mL of EtOAc
was added 10% Pd/C (9.3 mg, 0.088 mmol). The reaction
mixtures were shaked under the Parr hydrogenation appa-
ratus under 50 psi H2 at rt for 24 h. The reaction mixtures